Sana Biotechnology, Inc.
USD3.45
+0.03 (+0.88%)
CEO
Steven D. Harr
IPO Date
2021-02-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.43
Prev. Close
$3.42
Day Low
$3.39
Day High
$3.52
52W Low
$2.60
52W High
$6.55
Market Cap
$0.96B
Volume
2.49M
| 90,000 |
| $2.96 |
| 5 Jun 2026 | Seitz Michelle | director | A-Award | Acquired | 90,000 | $2.96 |
| 5 Jun 2026 | REICIN ALISE | director | A-Award | Acquired | 90,000 | $2.96 |
| 5 Jun 2026 | Mulligan Richard | director | A-Award | Acquired | 90,000 | $2.96 |
| 5 Jun 2026 | Bishop Hans Edgar | director | A-Award | Acquired | 90,000 | $2.96 |
| 5 Jun 2026 | Bilenker Joshua H. | director | A-Award | Acquired | 90,000 | $2.96 |
| 5 Jun 2026 | NELSEN ROBERT | director, 10 percent owner: | A-Award | Acquired | 90,000 | $2.96 |
| 8 Apr 2026 | Bishop Hans Edgar | director | A-Award | Acquired | 7,763 | $0.00 |
| 27 Mar 2026 | PATEL DHAVALKUMAR DHIRAJLAL | EVP, Chief Scientific Officer | Disposed | 0 | $0.00 |